LewisTepermanMD

General Surgery • New York, NY

Transplantation

Director, Transplantation at Northwell Health, Professor of Surgery and Medicine at the Zucker School of Medicine at Hofstra/Northwell

Join to view full profile

Dr. Teperman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Teperman's full profile

Already have an account?

Office
403 E 34th St
New York, NY 10016
Phone+1 212-263-8134

Education & Training

UPMC Medical Education (Pittsburgh)Residency, Surgery, 1986 - 1987
Zucker School of Medicine at Hofstra/NorthwellResidency, Surgery, 1984 - 1986
New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 1981 - 1984
Icahn School of Medicine at Mount SinaiClass of 1981

Certifications & Licensure

NY State Medical License 1982 - 2026
PA State Medical License 1986 - 1994
American Board of Surgery Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013
New York Magazine: Top Doctors Castle Connolly, 2002-2013
Super Doctor SuperDoctors.com
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant Start of enrollment: 2007 Sep 01
Completed
Phase 2
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
Completed
Phase 3
Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer Start of enrollment: 2012 Jul 16
Completed
Phase 2
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
Completed
Phase 3
Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Start of enrollment: 2013 Apr 03
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

291 citations
Primary nonfunction of hepatic allografts with preexisting fatty infiltration.
Satoru Todo, Anthony J. Demetris, Leonard Makowka, Lewis Teperman, Luis G. Podesta
Transplantation. 1989-05-01
4 citations
Effectiveness of SARS-CoV-2 Decontamination and Containment in a COVID-19 ICU.
Zarina Brune, Cyrus E. Kuschner, Joseph Mootz, Karina W. Davidson, Robert C. F. Pena
International Journal of Environmental Research and Public Health. 2021-03-03
1838 citations
Model for end-stage liver disease (MELD) and allocation of donor livers
Russell H. Wiesner, Erick B. Edwards, Richard B. Freeman, Ann M. Harper, Ray Kim
Gastroenterology. 2003-01-01

Press Mentions

Moderna COVID-19 Vaccine Trial for People with Organ Transplant BeginsSeptember 21st, 2021
Northwell Gives Third COVID Vaccine to Cancer PatientsAugust 17th, 2021
Long Islanders with Weakened Immune Systems Still Wary of COVID-19June 14th, 2021
Join now to see all

Professional Memberships

American College of Surgeons - ACS
Member